July 2016 – Oral Cancer News

Henry Schein Donates Medical Supplies In Support of Free Oral Cancer Screening Events throughout the United States

Source: www.mysocialgoodnews.com Author: Api Potter Company’s Donation to Support 77 Screening Events in 2016 and 2017 by the Oral Cancer Foundation Press Release – MELVILLE, N.Y., July 25, 2016 – Henry Schein, Inc. (Nasdaq: HSIC) announced today that it is donating more than $10,000 in medical supplies to the Oral Cancer Foundation (OCF) in support of 77 free oral cancer screening events being held throughout the United States in 2016 and 2017. Each OCF-hosted event aims to boost awareness of the disease and increase early detection. The Company’s donation of gauze, tongue depressors, and disposable dental mirrors, facemasks, and gloves is an initiative of Henry Schein Cares, the Company’s global corporate social responsibility program, and continues the Company’s support of OCF’s screening events. OCF hosts the events in a range of locations, including pharmacy parking lots, health fairs, farmer’s markets, colleges, and OCF Walk/Run for Awareness events. “The health of our mouths greatly impacts our ability to eat and drink, communicate thoughts and ideas, and express feelings for loved ones,” said Brian Hill, Founder of the Oral Cancer Foundation. “When cancer affects our mouths, it does more than take away these everyday functions, it too often takes our lives. Our screening events are designed to identify signs of oral cancer before it ever gets that far, and we thank Henry Schein for this generous donation and its continued support of oral cancer awareness and early detection efforts.” The donation comes at a time when nearly 500,000 people worldwide are diagnosed annually [...]

Charlotte Parker2016-07-27T12:17:07-07:00July, 2016|OCF In The News, Oral Cancer News|

Knowledgeability, Attitude and Behavior of Primary Care Providers Towards Oral Cancer: a Pilot Study

Source: www.link.springer.com Authors: Neel Shimpi, Aditi Bharatkumar, Monica Jethwani, Po-Huang Cyou, Ingrid Glurich, Jake Blamer, Amit Acharya The objective of this study was to assess current knowledgeability, attitudes, and practice behaviors of primary care providers (PCPs) towards oral cancer screening. Applying a cross-sectional design, a 14-question survey was emailed to 307 PCPs practicing at a large, multi-specialty, rurally based healthcare system. Survey data were collected and managed using REDCap and analyzed applying descriptive statistics. A 20 % response rate (n = 61/307) was achieved for survey completion. Approximately 70 % of respondents were physicians, 16 % were nurse practitioners, and 13 % were physician assistants. Nearly 60 % of respondents were family medicine practitioners. Limited training surrounding oral cancer screening during medical training was reported by 64 %. Although 78 % of respondents reported never performing oral cancer screening on patients in their practice, >90 % answered knowledge-based questions correctly. Frequency rate for specialist referral for suspicious lesions by PCPs was 56 % “frequently”. Optimal periodicity for oral cancer screening on all patients selected by respondents was 61 % “annually”, 3 % “every 6 months”, 3 % “every visit”, 2 % “not at all”, and 31 % “unsure”. This study established a baseline surrounding current knowledgeability, practice patterns, and opinions of PCPs towards oral cancer screening at a single, large, regional healthcare system. In the absence of evidence-based support for population-based cancer screening, this study result suggests a need for better integration of oral cancer surveillance into the medical setting, supplemented by education and training with emphasis on assessment of high-risk patients to achieve early detection. [...]

Charlotte Parker2016-07-25T10:18:19-07:00July, 2016|Oral Cancer News|

Bucking the trend: Cody Kiser, bronc rider

Source: www.thecalifornian.com Author: Champ Robinson Cody Kiser always had a fascination with the rodeo. The 25-year-old out of Carson City, Nevada competed in the high school rodeo as a bull rider, but Kiser used that term loosely. “I was more of a bull getter-oner than a bull rider,” Kiser joked. “I had a bad tendency of holding onto the rope until the very last second.” This time, that bad habit would cause significant injuries during a high school rodeo competition when Kiser was 14. “I hit the ground and I don’t know if I was on my chest or my back, but one foot (of the bull) landed on my face and the other on my chest or back,” Kiser said. The impact of the bull crushed Kiser’s left side of his face that broke his hinge bone and jaw bone and shattered his cheek bone. Kiser had to undergo plastic surgery to fix the injuries which required two plates and eight screws to be inserted to do so. Kiser spent a year recovering from the accident before returning to riding – this time horses. “Riding bucking horses was something I always wanted to do,” Kiser said. “My dad (P.D. Kiser), that’s actually what he did. I thought I’d give that a go and turns out I was a little better at it and now I’m here today.” When Kiser returned to riding, the nerves were there, but in a good way. “I think I was more excited than anything,” [...]

Oral Cancer Foundation News Team - A2017-01-11T17:06:26-07:00July, 2016|OCF In The News, Oral Cancer News|

Alcohol consumption increases risk for seven types of cancer: Study

Source: perfscience.com Author: Diana Bretting An analysis of past health studies that have looked at the association between drinking and cancer has unveiled that having alcoholic beverages can increase the risk for seven types of cancer, including head, neck, esophageal, liver, colorectal and breast cancer. The analysis carried out by Jennie Connor of the University of Otago, in New Zealand included comprehensive reviews conducted by the prestigious organizations, which include the World Cancer Research Fund and the American Institute for Cancer Research among others. The researchers came to know that the risk did not go down even if there were different alcohol types like rum, whiskey, wine or beer. The risk increases with higher consumption, which as per the researchers is known as a dose-response relationship. Connor was of the view that there is little evidence suggesting that the risk lessens for head and neck and liver cancers when consumption declines. Dr. Susan Gapstur, Vice-President of the Epidemiology Research Program at the American Cancer Society, said that the analysis has strengthened what is already known about the link between alcohol and cancer. Dr. Gapstur said, “This is a review of an existing body of literature. Essentially the author has interpreted the literature to help people to understand. But it's not a study of any new data. These seven cancer sites have long been established”. Health officials were of the view that the study might help regular drinkers to cut their drinking habit. Dr. Jana Witt, of Cancer Research UK said [...]

Oral Cancer Foundation News Team - A2016-07-27T11:42:47-07:00July, 2016|Oral Cancer News|

Despite medical backing, HPV vaccine rates remain low amid sexual and moral controversy

Source: www.omaha.com Author: Rick Ruggles, World-Herald staff writer The HPV vaccine can reduce the rates of certain cancers, including many cervical and oral cancers, physicians and medical organizations say. But opposition by some individuals is strong, and HPV vaccination rates remain low when compared with other kinds of vaccinations recommended for adolescents. Because the human papillomavirus is sexually transmitted and seventh grade is considered the ideal time to receive the three-dose vaccine regimen, the issue is rife with sexual and moral implications. Perhaps more potent today, though, are Internet horror stories and concerns about side effects. A World-Herald Facebook request for views on the HPV vaccine generated far more negatives than positives. “NO NO & NO!! There is NO reason for this vaccine,” one wrote. Another called it a “deadly shot.” Two Omaha mothers who were interviewed expressed their belief that it’s wise to have children vaccinated, and said their kids suffered no side effects. But an Iowa man described health problems suffered by his daughter, and he and an Ohio physician believe the girl was injured by the HPV vaccinations. So mediocre are HPV vaccination rates that GSK, the maker of Cervarix, plans to cease distribution of its HPV vaccine in the United States in September. It will continue to supply it in many other nations, such as Great Britain, Germany, France and Mexico. The departure of Cervarix leaves the market to Gardasil, a vaccine produced by Merck. “GSK has made the decision to stop supplying Cervarix ... in [...]

Oral Cancer Foundation News Team - A2016-07-24T12:18:56-07:00July, 2016|Oral Cancer News|

Rate of HPV-associated cancers on the rise in U.S., according to new CDC report

Source: www.curetoday.com Author: Andrew J. Roth Though the first preventive human papilloma virus (HPV) vaccine was approved by the U.S. Food and Drug Administration 10 years ago, the incidence of HPV-associated cancers is on the rise. From 2008 to 2012, the number of HPV-associated cancers diagnosed per year increased by approximately 16 percent compared with the previous five-year period, according to a new report by the Centers for Disease Control and Prevention (CDC). Nearly all sexually active individuals in the U.S. will get at least one type of HPV in their lifetime, making it the most common sexually-transmitted infection in the country. And though about 90 percent of HPV infections will clear a person’s system within two years, some infections persist and can cause cervical cancers and some types of vulvar, oropharyngeal, penile, rectal and cancers. There are over 40 HPV types, and vaccines are available for HPV types 16 and 18 (which account for 63 percent of HPV-associated cancers), as well as for types 31, 33, 45, 52 and 58 (which account for an additional 10 percent). Type 16 is the most likely to persist and develop into cancer. In this new report, the CDC analyzed data from its own National Program of Cancer Registries as well as the National Cancer Institute’s Surveillance, Epidemiology and End Results (SEER) database. In total, 38,793 HPV-associated cancers (11.7 per 100,000 persons), on average, were diagnosed annually from 2008 to 2012 compared with 33,369 diagnoses (10.8 per 100,000 persons) from 2004 to 2008. [...]

Oral Cancer Foundation News Team - A2016-07-16T15:47:18-07:00July, 2016|Oral Cancer News|

HPV-related cancer Is ‘epidemic’—but few get vaccinated

Source: www.newser.com Author: Michael Harthorne, Newser Staff "Every parent should ask the question: If there was a vaccine I could give my child that would prevent him/her from developing six different cancers, would I give it to them?” Electra Paskett, co-director of the Cancer Control Research Program at Ohio State University, tells CBS News. The answer appears to be no. According to NBC News, a CDC report released Thursday shows a 17% increase in HPV-related cancers between 2004 and 2012 to nearly 39,000 per year. Dr. Lois Ramondetta, an expert in gynecologic oncology, says it's become an "epidemic" especially for men, in whom HPV can cause cancers of the mouth, tongue, and throat. HPV increases the risk of those cancers by at least seven times, and unlike with HPV-caused cervical cancer in women, there's no screening for them. The CDC report found 93% of all HPV-related cancers could be prevented with the currently available vaccine. That's approximately 28,500 fewer cases of cancer every year, AFP reports. And yet in 2014, only 40% of teen girls and 22% of teen boys received the necessary three doses of the vaccine, which works best if administered before teens become sexually active. Paskett calls those numbers "extremely sad." “We must change the perception of the HPV vaccine from something that prevents a sexually transmitted disease to a vaccine that prevents cancer," she tells CBS. (Some British teens invented condoms that change color near HPV and other STDs.)

Oral Cancer Foundation News Team - A2016-07-11T21:21:07-07:00July, 2016|Oral Cancer News|

Rodeo Competitors Fight Smokeless Tobacco Use at Laramie Jubilee Days

Source: www.y95country.comAuthor: Nick Learned Two professional rodeo contestants will ride exclusively for the Oral Cancer Foundation this weekend as part of Laramie Jubilee Days with a goal of preventing young fans from using smokeless tobacco. Cody Kiser and Carly Twisselman each aim to show rodeo fans, particularly the younger ones, chewing or using other forms of smokeless tobacco isn’t what makes them who they are. They promote the Foundation’s campaign which uses the slogan “Be Smart. Don’t Start.” Their approach is anything but confrontational or aggressive. Rather than encouraging people to quit, they hope to encourage young fans to never pick up the habit in the first place. And where some rely on statistics to make the point, Kiser and Twisselman take a different approach. Simply giving attention to young rodeo fans is a big part of getting their message across. “Its not the facts that they’re going to take home,” Kiser says. “Everybody knows that tobacco’s bad; you can get cancer and you can die. But the biggest impact that I see is just acknowledging those kids or acknowledging those people in the audience that want to know more, and you can show them what you can do without tobacco.” “I’m not out there to tell anybody how to live their life or preach to them about needing to quit,” Kiser says. “It’s not our place to do that,” Twisselman says. “People most of the time aren’t going to listen when you tell them something like that anyway.” The pair will be wearing Oral Cancer Foundation gear [...]

Charlotte Parker2016-07-08T11:15:42-07:00July, 2016|OCF In The News, Oral Cancer News|

Rodeo outreach program fights oral cancer

Source: www.olivesoftware.comAuthor: Stewart M. Green Carly Twisselman, a spokesperson with the Oral Cancer Foundation’s rodeo outreach program, and her horse Chanel travel the Western rodeo circuit and talk with kids about the dangers of using spit tobacco. Photo by Stewart M. Green Carly Twisselman brushed her horse Chanel outside a stall at the Norris-Penrose Event Center, home of the Pikes Peak or Bust Rodeo, which will roll into town July 13-16. “I’ve been rodeoing my whole life,” she said. “Now I do it at the professional level. This is my rookie year so I’m going really hard. I want to win the rookie title.” Summer is the busiest time of the year for cowgirls and cowboys. “We call it Cowboy Christmas, the 4th of July run,” she said. Twisselman and her travel partner have recently competed in Utah, Nevada, Arizona, New Mexico, and just drove up from Pecos, Texas, to Colorado Springs for qualifiers. “It’s a crazy time,” she said. “Lots of traveling, but lots of money to be won.” Twisselman, a 30-year-old barrel racer, grew up on a ranch near San Luis Obispo on the central California coast. “My family’s been ranching there for seven generations,” she said. “I was on the back of a horse all the time. I was riding before I could walk.” While growing up in the Western ranching and rodeo culture, Twisselman was aware of the widespread use of spit tobacco by cowboys. “I’ve been around it my whole life and seen a lot [...]

Charlotte Parker2016-07-06T17:39:17-07:00July, 2016|OCF In The News, Oral Cancer News|

HPV vaccine important preventive tool for survivors of childhood cancer

Source: www.curetoday.com Author: Ellie Leick As childhood cancer survivors are at an increased risk of developing second cancers later in life, James Klosky recommends that this population receive the human papillomavirus (HPV) series of vaccines. A survey of 679 survivors one to five years out of treatment was conducted to evaluate how many received the vaccine compared with their healthy peers. A great disparity was discovered, as survivors — all of whom were between age 13 and 26 — were less likely to receive the vaccine. Researchers also investigated the reasons why many survivors did not receive it. Klosky, an associate member and director of psychological services in cancer survivorship at St. Jude Children’s Research Hospital, presented the findings from this research at the 2016 Annual Meeting of the American Society of Clinical Oncology (ASCO), a gathering of 30,000 oncology professionals in Chicago. CURE spoke with Klosky at the meeting to discuss the key takeaways and the importance of the HPV vaccine to survivors of childhood cancer. Can you give an overview of the study and its purpose? The HPV vaccine is the first vaccine that’s designed to prevent cancers. We are particularly interested in the application of this vaccine amongst survivors of childhood cancers, who are at increased risk for HPV-related cancers in young adulthood relative to their healthy peers. On average, the onset of these cancers occur seven years earlier in survivors of childhood cancers compared to their healthy peers. Additionally, survivors of childhood cancer have an increased [...]

Oral Cancer Foundation News Team - A2016-07-01T19:47:53-07:00July, 2016|Oral Cancer News|